These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 8327864

  • 1. [In-vitro and in-vivo studies on the selective immunoadsorption treatment of neurological diseases].
    Heininger K.
    Schriftenr Neurol; 1993; 33():1-91. PubMed ID: 8327864
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Immunoadsorption--a new treatment of myasthenia gravis].
    Berning T, Krummenerl T, Glaser J, Paulus H, van Husen N.
    Med Klin (Munich); 1988 Feb 26; 83(4):125-8. PubMed ID: 3285161
    [No Abstract] [Full Text] [Related]

  • 6. Semi-selective immunoadsorption treatment in myasthenia gravis.
    Splendiani G, Passalacqua S, Barbera G, Sturniolo G, Costanzi S, Fulignati P, Casciani CU.
    Biomater Artif Cells Immobilization Biotechnol; 1992 Feb 26; 20(5):1145-51. PubMed ID: 1457688
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Evaluation of plasma exchange in management of myasthenia gravis (author's transl)].
    Arahata K, Sato T, Narabayashi H.
    Rinsho Shinkeigaku; 1981 Jul 26; 21(7):597-606. PubMed ID: 7307400
    [No Abstract] [Full Text] [Related]

  • 9. Immunoadsorption therapy for myasthenia gravis.
    Shibuya N, Sato T, Osame M, Takegami T, Doi S, Kawanami S.
    J Neurol Neurosurg Psychiatry; 1994 May 26; 57(5):578-81. PubMed ID: 8201327
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [The use of therapeutic apheresis in neurological diseases and comparison between plasma exchange and immunoadsorption].
    Loschiavo C, Grecò M, Polo A, Del Colle R.
    G Ital Nefrol; 2015 May 26; 32(1):. PubMed ID: 25774587
    [Abstract] [Full Text] [Related]

  • 12. [Clinical study of double filtration plasmapheresis for treatment of refractory myasthenia gravis].
    Huo JT, Long HL, Luo X, Xu JZ.
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar 26; 27(3):355-7. PubMed ID: 17425991
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Changes of plasma proteins after immunoadsorption using Ig-Adsopak columns in patients with myasthenia gravis.
    Pták J.
    Transfus Apher Sci; 2004 Apr 26; 30(2):125-9. PubMed ID: 15062750
    [Abstract] [Full Text] [Related]

  • 15. [A case of myasthenia gravis with anti-MuSK antibodies showing a dramatic improvement with plasma exchange].
    Suzuki H, Motomura M, Yoshimura T, Shiraishi H, Mitsui Y, Hasegawa T, Atsumi M, Kitaguchi M, Kusunoki S.
    Rinsho Shinkeigaku; 2005 Jul 26; 45(7):510-3. PubMed ID: 16119834
    [Abstract] [Full Text] [Related]

  • 16. [Plasma exchange combined with immunosuppressive therapy in myasthenia gravis].
    Tanaka M, Nagai H, Mori S, Miyatake T, Shinada S.
    No To Shinkei; 1982 Jul 26; 34(7):699-703. PubMed ID: 7138697
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Therapeutic apheresis in myasthenia gravis.
    Batocchi AP, Evoli A, Di Schino C, Tonali P.
    Ther Apher; 2000 Aug 26; 4(4):275-9. PubMed ID: 10975473
    [Abstract] [Full Text] [Related]

  • 19. Effect of IgG immunoadsorption on serum cytokines in MG and LEMS patients.
    Baggi F, Ubiali F, Nava S, Nessi V, Andreetta F, Rigamonti A, Maggi L, Mantegazza R, Antozzi C.
    J Neuroimmunol; 2008 Sep 15; 201-202():104-10. PubMed ID: 18644634
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.